Incidence of severe streptococcal-related diseases in Italian children in an era of high group a streptococcal resistance to macrolides

Journal of Chemotherapy

Volumn 11, Issue 5, 1999, Pages 379-384

  Principi, Nicola ^a   Marchisio, P ^a   Bona, G ^b   Bonora, G ^b   Caramia, G ^b   Cavazzuti, G B ^b   Cocuzza, S ^b   Coppa, A ^b   Cordelli, F ^b   Di Toro, R ^b   Chiarelli, F ^b   Gardoni, L ^b   Gargantini, L ^b   Giovannelli, G ^b   Lombardo, G ^b   Longhi, R ^b   Mammi C ^b   Meloni, T ^b   Nespoli, L ^b   Panizon, F ^b   Re, D ^b   Reali, E ^b   Rigillo, N ^b   Rossoni, R ^b   Schettini, F ^b   Segni, G ^b   Spada, A ^b   Tato L ^b   Tenore, A ^b   Ugazio, A G ^b   Vaccari, A ^b   Vaccaro, R ^b   Virdis, A ^b   Volpato, S ^b   Zannino, L ^b   more..

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Beta lactam antibiotics; Group A streptococci; Macrolides; Resistance to macrolides; Streptococcal related disease; Streptococci

Indexed keywords

AMOXICILLIN; AZATHIOPRINE; BETA LACTAM ANTIBIOTIC; MACROLIDE;

ADOLESCENT; ANAPHYLACTOID PURPURA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CHILD; CHILDHOOD DISEASE; FEMALE; GLOMERULONEPHRITIS; HOSPITALIZATION; HUMAN; INFANT; ITALY; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; NECROTIZING FASCIITIS; PERITONSILLAR ABSCESS; RETROPHARYNGEAL ABSCESS; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

EID: 0032733106     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.5.379     Document Type: Article

References (21)

1. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis J 1997; 25: 574-583.
2. Maruyama S, Yoshioka H, Fujiita K, Takimoto M, Satake Y. Sensitivity of group A streptococci to antibiotics: prevalence of resistance to erythromycin in Japan. Am J Dis Child 1979; 133: 1143-1145.
3. Hsueh PR, Chen HM, Huang AH, Wu JJ. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 1995; 39: 2239-2242
4. Seppala H, Klaukka T, Lehtonen R, Nenonen E, the Finnish Study Group for Antimicrobial Resistance, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis J 1995; 21: 1378-1385.
5. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075-1078.
6. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441-446.
7. Scopetti F, Pataracchia M, Pacifico L et al. A multicenter study on antimicrobial susceptibility and typing of group A streptococci (GAS) from cases of pharyngo-tonsillitis and scarlet fever. Microec. Ther 1995; 25: 348-355.
8. Cocuzza CE, Mattina R, Mazzariol A et al. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis. An epidemiological and molecular study. Microb Drug Resist-Mechan Epidemiol Dis 1997; 3: 371-378.
9. Cornaglia G, Ligozzi M, Mazzariol A et al. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg Infect Dis 1996; 2: 339-342.
10. Schito GC, Pesce A, Marchese A. The role of macrolides in Streptococcus pyogenes pharyngitis. J Antimicrob Chemother 1997; 39: 562-565.
11. Data Source: IMS (Institute for Medical Statistics), Italia, Spa (Milan, Italy)- Servizio IMF- II Mercato Farmaceutico, 1990-1996.
12. Rathore MH, Barton LL, Kaplan EL. Suppurative group A beta hemolytic streptococcal infections in children. Pediatrics 1992; 89: 743-746.
13. Markowitz M. Changing epidemiology of group A streptococcal infections. Pediatr Infect Dis J 1994; 13: 557-560.
14. Stevens DL. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994; 13: 561-566.
15. Cocuzza CE, Blandino G, Mattina R, Nicoletti F, Nicoletti G. Antibiotic susceptibility of group A streptococci in two Italian cities: Milano and Catania. Microb Drug Resist-Mechan Epidemiol Dis 1997; 3: 379-384.
16. Ginsburg CM, McCracken GH, Culbertson MD. Concentrations of erythromycin in scrum and tonsil: comparison of the estolate and ethylsuccinate suspensions. J Pediatr 1976; 48: 417-422.
17. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25, Suppl. A: 73-82.
18. Scaglione F, Pintucci JP, Tassi GF et al. Penetration of clarythromycin into oral and respiratory tissues. Drug Investigat 1993; 6: 104-109.
19. Seppala H, Nissinen A, Jarvinen H et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326: 292-297.
20. Bassetti D, Ferrando A, Manno G. et al. In vitro resistance and in vivo efficacy in S. pyogenes pharyngotonsillitis: a pilot experience. In: Abstracts of the Fourth International Conference on the macrolides, azalides, streptogramins & ketolides. Barcelona, Spain, 1998. Abstract 9.07, p. 88.
21. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J 1993; 12: 268-274.